| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.002 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.59 | 0.004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.005 |